{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:44:26Z","timestamp":1777859066748,"version":"3.51.4"},"reference-count":18,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Prim Care Community Health"],"published-print":{"date-parts":[[2023,1]]},"abstract":"\n Purpose:<\/jats:title>\n The new era of direct-acting antivirals (DAAs) against the hepatitis C virus (HCV) has led many primary care clinicians to begin treating HCV. Nevertheless, many patients are referred to specialists due to comorbidities, care complexities, and knowledge gaps of the primary care provider. We compared clinical outcomes for patients treated within a Family Medicine Residency Program (FMRP) affiliated patient-centered medical home (PCMH) with those referred to a specialist.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Following didactic education and development of practice resources we conducted a single-center quasi-experimental study of adults with HCV referred for treatment either internally or externally to a specialist between January 2019 and December 2020. The primary outcome was the number of patients with a sustained virologic response at 12\u2009weeks after treatment (SVR12), utilizing an intention-to-treat analysis.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n During the study period 107 patients were assessed by the PCMH, of whom 24 were deemed not a good candidate for treatment. Of the 83 patients referred for treatment, 36 patients were referred externally and 47 were treated internally. While the rate of SVR12 was 100% for both groups when analyzed per protocol (ie, only patients who completed treatment and attended all follow-ups), the rate of SVR12 was 31% for patients referred externally and 62% for patients treated internally when analyzed by intention to treat (relative risk [RR] 2.02, 95% CI 1.18-3.47, P\u2009=\u2009.01). This difference was entirely attributable to differences in lost to follow-up rates.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Following education and creation of practice resources, achievement of SVR12 among patients with HCV treated by an internal interdisciplinary family medicine team was superior to those who were externally referred. This was primarily attributable to differences in follow-up rates.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/21501319231219576","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T03:40:25Z","timestamp":1703216425000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher Hepatitis C Cure Rates in a Patient-Centered Medical Home Compared to Specialist Care"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2595-8835","authenticated-orcid":false,"given":"Jonathan","family":"Hughes","sequence":"first","affiliation":[{"name":"Ascension Saint Thomas Rutherford, Murfreesboro, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Hodge","sequence":"additional","affiliation":[{"name":"Ascension Saint Thomas Rutherford, Murfreesboro, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Shadoan","sequence":"additional","affiliation":[{"name":"University of Tennessee Nashville Family Medicine Residency Program, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Ellis","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Pharmacy, Knoxville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Turner","sequence":"additional","affiliation":[{"name":"Ascension Saint Thomas Rutherford, Murfreesboro, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Glass","sequence":"additional","affiliation":[{"name":"University of Tennessee Nashville Family Medicine Residency Program, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"bibr1-21501319231219576","unstructured":"CDC. 2019 Viral Hepatitis Surveillance Report | CDC. October 1, 2021. Accessed October 16, 2021. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2019surveillance\/index.htm"},{"key":"bibr2-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.03.011"},{"key":"bibr3-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab779"},{"key":"bibr4-21501319231219576","unstructured":"Mitruka K, Thornton K, Cusick S, et al. Expanding Primary Care Capacity to Treat Hepatitis C Virus Infection Through an Evidence-Based Care Model \u2014 Arizona and Utah, 2012\u20132014. Accessed October 16, 2021. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6318a2.htm"},{"issue":"7","key":"bibr5-21501319231219576","first-page":"413","volume":"98","author":"Andrews RR.","year":"2018","journal-title":"Am Fam Physician"},{"key":"bibr6-21501319231219576","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2019.03.180286"},{"issue":"8","key":"bibr7-21501319231219576","first-page":"631","volume":"48","author":"Webb Camminati C","year":"2016","journal-title":"Fam Med"},{"key":"bibr8-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2069"},{"key":"bibr9-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1177\/1178633719841381"},{"key":"bibr10-21501319231219576","doi-asserted-by":"publisher","DOI":"10.22454\/PRiMER.2021.532368"},{"key":"bibr11-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8434602"},{"key":"bibr12-21501319231219576","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0118"},{"key":"bibr13-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"bibr14-21501319231219576","unstructured":"CDC. 2021 Viral Hepatitis Surveillance Report | CDC. August 23, 2023. Accessed October 6, 2023. https:\/\/nastad.org\/blog\/cdc-issues-2021-viral-hepatitis-surveillance-report"},{"key":"bibr15-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009370"},{"key":"bibr16-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(16)01600-7"},{"key":"bibr17-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4635-7"},{"key":"bibr18-21501319231219576","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz546"}],"container-title":["Journal of Primary Care & Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/21501319231219576","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/21501319231219576","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/21501319231219576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:24:22Z","timestamp":1777508662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/21501319231219576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":18,"alternative-id":["10.1177\/21501319231219576"],"URL":"https:\/\/doi.org\/10.1177\/21501319231219576","relation":{},"ISSN":["2150-1319","2150-1327"],"issn-type":[{"value":"2150-1319","type":"print"},{"value":"2150-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"21501319231219576"}}